Awakn Life Sciences Corp. announced today the completion of the world's first ketamine treatment study for behavioral addictions.

Maxwell™ Preclinical MRI Magnets do not require liquid helium, facilitating siting.

Beckman Coulter announces it will introduce new antipsychotic drug tests to laboratories and clinicians to address an unmet clinical need for 69 million people with serious mental conditions worldwide.

Eppendorf and the journal Science are now accepting applications for the 2022 Eppendorf & Science Prize for Neurobiology.

Analysis indicates viability of research pathway for MDMA-assisted therapy to treat symptoms associated with traumatic brain injury.

Cambridge, UK, based sample management experts - Ziath Ltd are putting a bit of Christmas cheer in the hearts and minds of young people in London suffering from mental health issues.